Hazelbaker DZ, Beccard A, Bara AM et al. A scaled framework for CRISPR editing of human pluripotent stem cells to study psychiatric disease. Stem Cell Rep. 2017;9(4):1315-1327.
Bara AM, Messana A, Herring A, et al. Generation of a TLE3 heterozygous knockout human embryonic stem cell line using CRISPR-Cas9. Stem Cell Res. 2016;17(2):441-443.
Herring A, Messana A, Bara AM, et al. Generation of a TLE1 homozygous knockout human embryonic stem cell line using CRISPR-Cas9. Stem Cell Res. 2016;17(2):430-432.
Lindy Barrett, Ph.D.
Lindy Barrett is a senior group leader in the Stanley Center for Psychiatric Research of the Broad Institute of MIT and Harvard. In addition to her role at the Broad, she is also an affiliate in Harvard University’s Department of Stem Cell and Regenerative Biology.
Barrett and her lab use a combination of human pluripotent stem cell biology, genome-engineering technologies, and in vitro differentiation to study the impact of genes and variants implicated in neurodevelopmental diseases on neuronal function.
Barrett holds a bachelor’s degree from the University of Chicago and a Ph.D. in neuroscience from the University of Pennsylvania School of Medicine. She completed her postdoctoral training at Memorial Sloan-Kettering Cancer Center before joining the Broad Institute in 2014.
Contact Lindy Barrett via email at email@example.com.